Azita Saleki-Gerhardt is the Executive Vice President and Chief Operations Officer at AbbVie Inc., a global biopharmaceutical company. In her role, she is responsible for overseeing the company's global operations, including manufacturing, supply chain, and quality assurance. Saleki-Gerhardt has been with AbbVie since its inception in 2013, having previously worked at Abbott Laboratories, AbbVie's parent company, for over two decades. Throughout her career, Saleki-Gerhardt has demonstrated exceptional leadership and expertise in the pharmaceutical industry. She has held various positions of increasing responsibility at Abbott and AbbVie, including roles in research and development, technical operations, and quality assurance. Her contributions have been instrumental in the successful development and commercialization of several of AbbVie's key products, including Humira, one of the world's top-selling drugs. Saleki-Gerhardt's strategic vision and operational excellence have been crucial in driving AbbVie's growth and maintaining its position as a leader in the biopharmaceutical industry. As Chief Operations Officer, Saleki-Gerhardt plays a vital role in ensuring that AbbVie continues to deliver high-quality, innovative medicines to patients worldwide. She leads a team of over 10,000 employees across multiple sites, focusing on optimizing processes, implementing cutting-edge technologies, and fostering a culture of continuous improvement. Her commitment to operational excellence and patient-centricity has earned her recognition as a respected leader in the industry. Under her guidance, AbbVie is well-positioned to meet the evolving needs of patients and healthcare providers while maintaining the highest standards of quality and efficiency.